In Vivo and in Vitro Myocardial Binding of Risperidone and 9-Hydroxyrisperidone
- 15 April 2002
- journal article
- Published by Elsevier BV in Toxicology and Applied Pharmacology
- Vol. 180 (2), 145-149
- https://doi.org/10.1006/taap.2002.9383
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Antipsychotic Drugs: Prolonged QTc Interval, Torsade de Pointes, and Sudden DeathAmerican Journal of Psychiatry, 2001
- Antipsychotic drugs and heart muscle disorder in international pharmacovigilance: data mining studyBMJ, 2001
- Long-term treatment with antipsychotic drugs in conventional doses prolonged QTc dispersion, but did not increase ventricular tachyarrhythmias in patients with schizophrenia in the absence of cardiac disease.European Journal of Clinical Pharmacology, 1999
- Therapeutic Drug Monitoring of Risperidone Using a New, Rapid HPLC Method: Reappraisal of Interindividual Variability FactorsTherapeutic Drug Monitoring, 1999
- Atypical Antipsychotics: Part II Adverse Effects, Drug Interactions, and CostsAnnals of Pharmacotherapy, 1999
- Atypical antipsychotics. Part I: Pharmacology, pharmacokinetics, and efficacy.Annals of Pharmacotherapy, 1999
- Prolongation of QT Interval in Isolated Feline Hearts by Antipsychotic DrugsJournal of Clinical Psychopharmacology, 1998
- Distribution after repeated oral administration of different dose levels of risperidone and 9-hydroxy-risperidone in the brain and other tissues of rat.Psychopharmacology, 1998
- In vitro electrophysiological detection of iatrogenic arrhythmogenicityFundamental & Clinical Pharmacology, 1994
- In vitro andin vivo evaluation of the tissue-to-blood partition coefficient for physiological pharmacokinetic modelsJournal of Pharmacokinetics and Biopharmaceutics, 1982